The recent outbreak of Coronavirus (COVID-19) has impacted the lives of almost all parts of the world. Governments of different countries are trying hard to contain the spread of this virus and for that, they are taking all the precautionary measures. The pandemic has led to the use of different types of swabs and kits to conduct the test of collected samples to detect COVID-19.
For ensuring the accuracy of COVID-19 tests, the Centers for Disease Control and Prevention and other related organizations have brought the set of standards guidelines and procedures. These guidelines ensure effective specimen collection and effectively manage the adoption of COVID-19 sample collection kits.
A rapid surge in cases of COVID-19 globally driving huge demand for sample collection kits and regulatory authorities are also approving advanced & latest detection tests that are projected to drive the market for COVID-19 sample collection kits. The rising demand for rapid diagnostic tests that can provide quick results along with the shortage of testing instruments has bolstered the demand for antigen and antibody test kits. Continuous efforts by leading companies for research and development of advanced testing materials are expected to drive the market growth significantly over a period of time.
Key Trend in COVID-19 Sample Collection Kits Market
- The Nasopharyngeal (NP) swabs segment is anticipated to capture the largest revenue share on account of the major dependence of RT-PCR assays on NP swabs. Various healthcare institutes as well as and testing service providers started collaborating with key market participants for having an ample supply of NP swabs to test patients at a large scale.
- Despite challenges related to time and cost, molecular assay emerged as the major detection method due to its high specificity and sensitivity. As an outcome of this, the kits used for RT-PCR-based molecular assay are estimated to exhibit a significant rise in demand worldwide.
- World’s leading tech giant Apple has provided the manufacturing help to nasal swab maker COPAN Diagnostics and they have provided 15 million COVID-19 kits across Texas, California, and other US states. This will largely solve the issue of kits shortage and allow hospitals to effectively conduct rapid tests for COVID-19.
Regional Developments for COVID-19 Sample Collection Kits Market
North America is predicted to account for the largest share of the COVID-19 sample collection kits market. The regional market is expected to grow at a rapid pace owing to the rise in research & development activities coupled with increasing government initiatives to introduce advanced medical equipment. Europe is projected to emerge as the second-largest market, followed by the Asia Pacific. Increasing investments by public-private organizations and improvement in healthcare management are driving growth for the market in these regions.
Leading Players Operating in COVID-19 Sample Collection Kits Market
The global market for the COVID-19 sample collection kits market has become highly competitive and consolidated with the presence of several leading players investing heavily in product innovations. Some of the major players holding a dominant position in the market include: COPAN Diagnostics, Thermo Fisher Scientific, Inc., Hardy Diagnostics, Medline Industries, Inc., Puritan Medical Products, HiMedia Laboratories, and Lucence Diagnostics Pte Ltd. Companies are boosting up their production line to meet the rising demand for sample collection kits.
Deep-dive Insights on COVID-19 Sample Collection Kits Market by Polaris Market Research: https://www.polarismarketresearch.com/industry-analysis/covid-19-sample-collection-kits-market/request-for-sample